Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy

Erstveröffentlichung

2017

Authors

Hiller, Jan K.

Schmoor, Claudia

Gaidzik, Verena Ingeborg

Schmidt-Salzmann, Charlotte

Yalcin, Arzu

et al.

Wissenschaftlicher Artikel

Published in

Annals of Hematology ; 96 (2017), 4. - S. 559-565. - ISSN 0939-5555. - eISSN 1432-0584

Link to publication

https://dx.doi.org/10.1007/s00277-016-2912-7

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: AML | Decitabine | Epigenetics | Biomarker | conventional care regimens | dnmt3a mutations | older patients | 1st-line treatment | phase-ii | azacitidine | multicenter | adults
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record